Analyst Reco.

01-14 Evans & Partners Starts ALS at Positive with AU$25.80 Price Target MT
11-17 ALS Expected to Disclose 'Strong' Fiscal H2 Guidance, Says Jefferies. MT
30/10/25 ALS' Exploration Activity to Pick Up Amid Gold, Copper Boom, Jefferies Says MT
09/09/25 Barrenjoey Markets Upgrades ALS to Overweight from Neutral; Price Target is AU$20.95 MT
29/05/25 ALS' AU$390 Million Equity Raise 'Opportunistic,' Says Jarden MT
28/05/25 Jarden Adjusts ALS' Price Target to AU$14.60 from AU$15, Keeps at Underweight MT
23/05/25 Jarden Research Downgrades ALS to Underweight from Neutral, Adjusts Price Target to AU$15 from AU$14.50 MT
21/11/24 ALS Set for Potential Upside to Earnings Outlook, Jarden Research Says MT
20/11/24 Jarden Downgrades ALS to Neutral from Overweight, Adjusts Price Target to AU$14.40 from AU$14.25 MT
22/09/24 ALS Geochemistry Business Volumes Deteriorating, But Life Sciences Unit Remains Resilient, Says Jarden Research MT
20/09/24 Jarden Research Adjusts ALS' Price Target to AU$14.20 from AU$14.90; Keeps at Overweight MT
22/07/24 UBS Upgrades ALS Limited to Buy From Neutral; Price Target is AU$17 MT
22/05/24 Jarden Downgrades ALS to Overweight From Buy, Adjusts Price Target to AU$14.90 From AU$13.70 MT
02/04/24 Morgans Financial Downgrades ALS to Hold from Add, Price Target at AU$13.70 MT
25/03/24 Jarden Adjusts ALS's Price Target to AU$13.70 from AU$13.80, Keeps at Buy MT
21/03/24 Jarden Adjusts ALS' Price Target to AU$13.80 From AU$13.40, Keeps at Buy MT
25/08/22 UBS Adjusts ALS' Price Target to AU$13.15 From AU$13.10, Keeps at Neutral MT
02/03/22 UBS Adjusts ALS' Price Target to AU$13.30 From AU$13.50, Keeps at Neutral MT
No results for this search
SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW